An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

BAXDELA® (POWDER)

Drug Information Related Patent
Hold Company
MELINTA
Learn More
Dosage and Administration
POWDER;INTRAVENOUS
Specification
EQ 300MG BASE/VIAL
Indication
BAXDELA® is used for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia.
Use
Instructions for Use
API
DELAFLOXACIN MEGLUMINE
API Structure
We Supply
DELAFLOXACIN MEGLUMINE
Note:

In-house Standard
Facility GMP

null
Note:

null

null
Note:

null

Drug Patent
Patent NoExpiration Date
76357732029/3/13
77281432031/6/19
82528132026/10/2
82738922026/8/6
84100772029/3/13
86480932025/10/7
88719382029/9/23
92000882029/3/13
94935822033/2/27
95392502025/10/7
97508222029/3/13
RE466172029/12/28
84973782029/12/28
API Patent
Patent NoExpiration Date
82528132026/10/2
82738922026/8/6
86480932025/10/7
95392502025/10/7

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top